首页 › 基金 › RICE HALL JAMES & ASSOCIATES, LLC › BMRN

RICE HALL JAMES & ASSOCIATES, LLC 对 BMRN 的持仓历史

BIOMARIN PHARMACEUTICAL INC · 医疗保健

RICE HALL JAMES & ASSOCIATES, LLC 在 Q3 2026 的 13F 申报中披露持有 BMRN(BIOMARIN PHARMACEUTICAL INC)376,343 股,市值约 US$22.6M,约占其申报组合的 1.20%,在其申报持仓中市值排名第 29 位。 RICE HALL JAMES & ASSOCIATES, LLC 最近 13 个申报季度中有 13 个季度披露了 BMRN 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)376.34K 股
申报持仓市值$22.58M
组合权重1.20%
首次申报Q3 2023
最近变动增持
更新于2026-11-16

最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR

RICE HALL JAMES & ASSOCIATES, LLC 对 BMRN 的持仓演变

RICE HALL JAMES & ASSOCIATES, LLC 于 Q3 2023 首次披露 BMRN 持仓:30,867 股(约 US$2.7M)。 该持仓在 Q3 2026 达到峰值 376,343 股,市值约 US$22.6M。 在 13 次申报中,RICE HALL JAMES & ASSOCIATES, LLC 5 次增持、7 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 376,343 股、市值约 US$22.6M,环比增持 128,119 股。。 持仓曾出现大幅变动:Q3 2025 增持约 1693% (随后一个季度股价上涨 10%)、Q2 2026 增持约 137% (随后一个季度股价上涨 5%)、Q3 2026 增持约 52% (随后一个季度股价下跌 5%)。

逐季持仓明细

季度股数金额变化
Q3 2023 30.87K $2.73M 新进
Q4 2023 29.41K $2.84M 减持
Q1 2024 28.72K $2.51M 减持
Q2 2024 20.68K $1.70M 减持
Q3 2024 10.33K $725.88K 减持
Q4 2024 5.79K $380.64K 减持
Q1 2025 5.88K $415.66K 增持
Q2 2025 5.77K $317.07K 减持
Q3 2025 103.42K $5.60M 增持
Q4 2025 100.17K $5.95M 减持
Q1 2026 104.66K $5.91M 增持
Q2 2026 248.22K $14.20M 增持
Q3 2026 376.34K $22.58M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 BMRN 与 13F 数据

BMRN(BIOMARIN PHARMACEUTICAL INC)属于医疗保健行业。我们追踪的基金中还有 26 只申报持有 BMRN,申报仓位最大的包括:PRIMECAP MANAGEMENT CO/CA/ (US$899.3M), 维京环球投资 (US$435.8M), VIKING GLOBAL INVESTORS LP (US$435.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 BMRN 的基金

查看 BMRN 的全部基金持有人 →

常见问题

How long has RICE HALL JAMES & ASSOCIATES, LLC held BMRN?

RICE HALL JAMES & ASSOCIATES, LLC has disclosed BMRN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is RICE HALL JAMES & ASSOCIATES, LLC's current position in BMRN?

As of Q3 2026, RICE HALL JAMES & ASSOCIATES, LLC holds 376.34K shares of BMRN (BIOMARIN PHARMACEUTICAL INC), valued at $22.58M, representing 1.20% of its reported portfolio and ranking #29.

Has RICE HALL JAMES & ASSOCIATES, LLC been buying or selling BMRN?

In the latest 13F filing (Q3 2026), RICE HALL JAMES & ASSOCIATES, LLC increased its position in BMRN. The position peaked in Q3 2026 at 376.34K shares.

Which other funds hold BMRN?

Other major institutional holders of BMRN include PRIMECAP MANAGEMENT CO/CA/, 维京环球投资, VIKING GLOBAL INVESTORS LP, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.